# OnCo record nct06608927 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06608927/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06608927", "NCT06608927" ;
  schema:name "Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma"@en ;
  schema:alternateName "PRISM-1"@en ;
  schema:description "A phase 3 trial testing Quemliclustat in pancreatic ductal adenocarcinoma, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06608927/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06608927> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-12-13" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:drugs <https://onco.cc/drugs/quemliclustat/> ;
  onco:companies <https://onco.cc/companies/arcus-biosciences/> .